- Report
- August 2025
- 189 Pages
Global
From €3218EUR$3,545USD£2,772GBP
€3576EUR$3,939USD£3,080GBP
- Report
- August 2025
- 188 Pages
Global
From €3218EUR$3,545USD£2,772GBP
€3576EUR$3,939USD£3,080GBP
- Report
- August 2025
- 187 Pages
Global
From €3218EUR$3,545USD£2,772GBP
€3576EUR$3,939USD£3,080GBP
- Report
- May 2026
- 180 Pages
Global
From €4085EUR$4,500USD£3,519GBP
- Report
- May 2026
- 185 Pages
Global
From €4085EUR$4,500USD£3,519GBP
- Report
- May 2026
- 182 Pages
Global
From €4085EUR$4,500USD£3,519GBP
- Report
- May 2026
- 185 Pages
Global
From €4085EUR$4,500USD£3,519GBP
- Report
- May 2026
- 192 Pages
Global
From €4085EUR$4,500USD£3,519GBP
- Report
- May 2026
- 180 Pages
Global
From €4085EUR$4,500USD£3,519GBP
- Report
- January 2026
- 185 Pages
Global
From €4085EUR$4,500USD£3,519GBP
- Report
- January 2026
- 180 Pages
Global
From €4085EUR$4,500USD£3,519GBP
- Report
- January 2026
- 183 Pages
Global
From €4085EUR$4,500USD£3,519GBP
- Report
- January 2026
- 186 Pages
Global
From €4085EUR$4,500USD£3,519GBP
- Report
- January 2026
- 185 Pages
Global
From €4085EUR$4,500USD£3,519GBP
- Report
- January 2026
- 180 Pages
Global
From €4085EUR$4,500USD£3,519GBP
- Report
- November 2025
- 185 Pages
Global
From €4085EUR$4,500USD£3,519GBP
- Report
- November 2025
- 183 Pages
Global
From €4085EUR$4,500USD£3,519GBP
- Report
- August 2025
- 188 Pages
Global
From €4085EUR$4,500USD£3,519GBP
- Report
- August 2025
- 198 Pages
Global
From €3218EUR$3,545USD£2,772GBP
€3576EUR$3,939USD£3,080GBP
- Report
- January 2026
- 185 Pages
Global
From €4085EUR$4,500USD£3,519GBP

The Blood Cell market is a subset of the biotechnology industry that focuses on the development of products and services related to the study and manipulation of blood cells. This includes the production of blood cell-based therapeutics, such as monoclonal antibodies, as well as the development of diagnostic tests and treatments for blood-related diseases. Blood cell research is also used to develop treatments for cancer, autoimmune diseases, and other conditions.
The Blood Cell market is a rapidly growing sector of the biotechnology industry, with new products and services being developed to meet the needs of patients and healthcare providers. Companies in this market are focused on developing innovative technologies and treatments to improve patient outcomes and reduce healthcare costs.
Some of the companies in the Blood Cell market include AbbVie, Amgen, AstraZeneca, Biogen, Celgene, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer, and Regeneron Pharmaceuticals. Show Less Read more